Currently, clinical studies on Nrf2 have focused on advanced kidney disease, with reports indicating that Nrf2 expression correlated with the degree of renal failure and comorbidities (8, 9) and Nrf2 expression varied among different types of immune cells and tissues (4). Here, NFE2L2 is linked to acute kidney injury.